Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
BioEclipse Therapeutics, Inc. See All Filings	C/A	2022-04-01 17:00:34 UTC
Financial Interest None. Filing Platform NetCapital Funding Portal Inc. Offering Amount $1,069,997 CIK Number 0001780708 Filed Document 0001669191-22-000335 Accepted Date 2022-04-01 17:00:34 UTC Type of Offering C/A Security Offered Amount 3,922 Security Offered Type Common Stock State CALIFORNIA
BioEclipse Therapeutics, Inc. See All Filings	C/A	2022-02-28 15:49:34 UTC
Financial Interest None. Filing Platform NetCapital Funding Portal Inc. Offering Amount $1,069,997 CIK Number 0001780708 Filed Document 0001669191-22-000203 Accepted Date 2022-02-28 15:49:34 UTC Type of Offering C/A Security Offered Amount 3,922 Security Offered Type Common Stock State CALIFORNIA
BioEclipse Therapeutics, Inc. See All Filings	C	2022-01-19 11:18:08 UTC
Financial Interest None. Filing Platform NetCapital Funding Portal Inc. Offering Amount $1,069,997 CIK Number 0001780708 Filed Document 0001669191-22-000053 Accepted Date 2022-01-19 11:18:08 UTC Type of Offering C Security Offered Amount 3,922 Security Offered Type Common Stock State CALIFORNIA
BioEclipse Therapeutics, Inc. See All Filings	D/A	2019-10-10 14:18:03 UTC
Amount To Be Raised $11,768,260 Associated Brokers / Dealers Venture.co Brokerage Services LLC CIK Number 0001780708 Filed Document 0001780708-19-000004 Exclusions or Exemptions 506b Accepted Date 2019-10-10 14:18:03 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
BioEclipse Therapeutics, Inc. See All Filings	D	2019-06-25 14:17:05 UTC
Amount To Be Raised $9,090,310 Associated Brokers / Dealers Venture.co Brokerage Services LLC CIK Number 0001780708 Filed Document 0001780708-19-000003 Exclusions or Exemptions 506b Accepted Date 2019-06-25 14:17:05 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity